| CHD | Coronary heart disease |
| CKD | Chronic kidney disease |
| CRP | C-reactive protein |
| CVD | Cardiovascular disease |
| DOACs | Direct oral anticoagulants |
| GGCX | γ-glutamyl carboxylase |
| Gas6 | Growth arrest-specific protein 6 |
| Gla | γ-carboxyglutamic acid |
| Glu | Glutamic acid |
| GRAS | Generally recognized as safe |
| GRP | Gla-rich protein |
| HD | Haemodialysis |
| IKB | IkappaB kinase |
| INR | International normalized ratio |
| KH2 | Vitamin K hydroquinone |
| KO | Vitamin K 2,3-epoxide |
| LDL | Low-density lipoproteins |
| 12-LOX | 12-lipoxygenase |
| LPS | Liposaccharide |
| LSF | Liquid-state fermentation process |
| MGP | Matrix-Gla protein |
| MKs | Menaquinones |
| MM | Mixed micelles |
| NF-κB | Nuclear factor kappa B |
| OA | Osteoarthritis |
| OC | Osteocalcin |
| PRGP1 | Proline-rich Gla proteins |
| RA | Rheumatoid arthritis |
| ROS | Reactive oxygen species |
| SSF | Solid-state fermentation process |
| TLR | Triacylglycerol-rich lipoproteins |
| TMG | Transmembrane Gla proteins |
| VC | Vascular calcification |
| VKAs | Vitamin K antagonists |
| VKDB | Vitamin K deficiency bleeding |
| VKDPs | Vitamin K-dependent proteins |
| VKORC1 | Vitamin K epoxide reductase complex subunit 1 |
| VKORC1L1 | Vitamin K epoxide reductase complex subunit 1-like 1 |
| WHO | World Health Organization |